Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |